{"id":"https://openalex.org/W1921787609","doi":"https://doi.org/10.1016/j.trci.2015.06.006","title":"Delayed\u2010start analysis: Mild Alzheimer's disease patients in solanezumab trials, 3.5 years","display_name":"Delayed\u2010start analysis: Mild Alzheimer's disease patients in solanezumab trials, 3.5 years","alternate_titles":[],"publication_year":2015,"publication_date":"2015-07-25","ids":{"openalex":"https://openalex.org/W1921787609","doi":"https://doi.org/10.1016/j.trci.2015.06.006","mag":"1921787609","pmid":"https://pubmed.ncbi.nlm.nih.gov/29854931","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5975050"},"language":"en","primary_location":{"id":"doi:10.1016/j.trci.2015.06.006","doi":"https://doi.org/10.1016/j.trci.2015.06.006","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.trci.2015.06.006","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.trci.2015.06.006","source":{"id":"https://openalex.org/S2898321583","display_name":"Alzheimer s & Dementia Translational Research & Clinical Interventions","issn_l":"2352-8737","issn":["2352-8737"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's &amp; Dementia: Translational Research &amp; Clinical Interventions","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1921787609"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.trci.2015.06.006","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085051732","display_name":"Hong Liu\u2010Seifert","orcid":"https://orcid.org/0000-0002-9534-0483","observed_orcids":["https://orcid.org/0000-0002-9534-0483"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Hong Liu\u2010Seifert","raw_affiliation_strings":["Eli Lilly and Company; Indianapolis, IN USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company; Indianapolis, IN USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080609944","display_name":"Eric Siemers","orcid":"https://orcid.org/0000-0001-7125-1550","observed_orcids":["https://orcid.org/0000-0001-7125-1550"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eric Siemers","raw_affiliation_strings":["Eli Lilly and Company; Indianapolis, IN USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company; Indianapolis, IN USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006059157","display_name":"Karen Chilcott Holdridge","orcid":"https://orcid.org/0009-0003-4390-5168","observed_orcids":["https://orcid.org/0009-0003-4390-5168"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Karen C. Holdridge","raw_affiliation_strings":["Eli Lilly and Company; Indianapolis, IN USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company; Indianapolis, IN USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103222160","display_name":"Scott W. Andersen","orcid":"https://orcid.org/0000-0002-2679-3921","observed_orcids":["https://orcid.org/0000-0002-2679-3921"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Scott W. Andersen","raw_affiliation_strings":["Eli Lilly and Company; Indianapolis, IN USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company; Indianapolis, IN USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033916270","display_name":"Ilya A. Lipkovich","orcid":"https://orcid.org/0000-0002-1936-2197","observed_orcids":["https://orcid.org/0000-0002-1936-2197"]},"institutions":[{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ilya Lipkovich","raw_affiliation_strings":["Quintiles, Inc.; Durham; NC; USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quintiles, Inc.; Durham; NC; USA","institution_ids":["https://openalex.org/I4210108991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110002052","display_name":"Christopher D. Carlson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christopher Carlson","raw_affiliation_strings":["Eli Lilly and Company; Indianapolis, IN USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company; Indianapolis, IN USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109144493","display_name":"Gopalan Sethuraman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gopalan Sethuraman","raw_affiliation_strings":["Eli Lilly and Company; Indianapolis, IN USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company; Indianapolis, IN USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055857626","display_name":"SHARON L. HOOG","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sharon Hoog","raw_affiliation_strings":["Eli Lilly and Company; Indianapolis, IN USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company; Indianapolis, IN USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110234410","display_name":"Roza Hayduk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Roza Hayduk","raw_affiliation_strings":["Quintiles, Inc.; Durham; NC; USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quintiles, Inc.; Durham; NC; USA","institution_ids":["https://openalex.org/I4210108991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068308578","display_name":"Rachelle Smith Doody","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rachelle Doody","raw_affiliation_strings":["Alzheimer's Disease and Memory Disorders Center, Department of Neurology, Baylor College of Medicine, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheimer's Disease and Memory Disorders Center, Department of Neurology, Baylor College of Medicine, Houston, TX, USA","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034225628","display_name":"Paul S. S Aisen","orcid":"https://orcid.org/0000-0002-2896-5838","observed_orcids":["https://orcid.org/0000-0002-2896-5838"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul Aisen","raw_affiliation_strings":["Alzheimer's Disease Cooperative Study, Department of Neurosciences; University of California at San Diego; San Diego CA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheimer's Disease Cooperative Study, Department of Neurosciences; University of California at San Diego; San Diego CA USA","institution_ids":["https://openalex.org/I36258959"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5085051732"],"corresponding_institution_ids":["https://openalex.org/I168537998"],"apc_list":{"value":2540,"currency":"USD","value_usd":2540},"apc_paid":{"value":2540,"currency":"USD","value_usd":2540},"fwci":3.7744,"has_fulltext":true,"cited_by_count":58,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.94689055,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"1","issue":"2","first_page":"111","last_page":"121"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.020400000736117363,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/solanezumab","display_name":"solanezumab","score":1.0},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9490000009536743},{"id":"https://openalex.org/keywords/non-inferiority-testing","display_name":"non-inferiority testing","score":0.8539999723434448},{"id":"https://openalex.org/keywords/anti-amyloid-monoclonal-antibodies","display_name":"anti-amyloid monoclonal antibodies","score":0.9100000262260437},{"id":"https://openalex.org/keywords/disease-modifying-effects","display_name":"disease-modifying effects","score":0.7870000004768372},{"id":"https://openalex.org/keywords/mild-alzheimer-s-disease","display_name":"mild Alzheimer's disease","score":0.7910000085830688},{"id":"https://openalex.org/keywords/placebo-crossover","display_name":"placebo crossover","score":0.6949999928474426},{"id":"https://openalex.org/keywords/instrumental-activities-of-daily-living","display_name":"instrumental activities of daily living","score":0.7749999761581421}],"concepts":[{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7973346710205078},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5564315915107727},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.5533803701400757},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46764373779296875},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4542759358882904},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4517981708049774},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.34426063299179077},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.33414754271507263},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08967426419258118},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1016/j.trci.2015.06.006","doi":"https://doi.org/10.1016/j.trci.2015.06.006","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.trci.2015.06.006","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.trci.2015.06.006","source":{"id":"https://openalex.org/S2898321583","display_name":"Alzheimer s & Dementia Translational Research & Clinical Interventions","issn_l":"2352-8737","issn":["2352-8737"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's &amp; Dementia: Translational Research &amp; Clinical Interventions","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5975050","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5975050/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimers Dement (N Y)","raw_type":"Text"},{"id":"pmid:29854931","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29854931","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & dementia (New York, N. Y.)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.trci.2015.06.006","doi":"https://doi.org/10.1016/j.trci.2015.06.006","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.trci.2015.06.006","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.trci.2015.06.006","source":{"id":"https://openalex.org/S2898321583","display_name":"Alzheimer s & Dementia Translational Research & Clinical Interventions","issn_l":"2352-8737","issn":["2352-8737"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's &amp; Dementia: Translational Research &amp; Clinical Interventions","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1129981694","display_name":null,"funder_award_id":"AG 10483","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G3081032344","display_name":"A Phase 2 Trial of AAV-NGF Gene Delivery in Alzheimer's Disease","funder_award_id":"R01AG030048","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G3146424788","display_name":null,"funder_award_id":"AG 024904","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G3870774570","display_name":null,"funder_award_id":"AG024904","funder_id":"https://openalex.org/F4320332193","funder_display_name":"Genentech"},{"id":"https://openalex.org/G4761962336","display_name":"Alzheimer's Disease Cooperative Study (ADCS)","funder_award_id":"U01AG010483","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G5707695498","display_name":"Alzheimer's Disease Neuroimaging Initiative","funder_award_id":"U01AG024904","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G7085631254","display_name":"VITAMIN E TRIAL IN PERSONS WITH DOWN SYNDROME","funder_award_id":"R01AG016381","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G9000122335","display_name":null,"funder_award_id":"AG024904","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000239186","display_name":null,"funder_award_id":"AG10483","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320306219","display_name":"Alzheimer's Association","ror":"https://ror.org/0375f4d26"},{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307776","display_name":"Merck","ror":"https://ror.org/02891sr49"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320337337","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1921787609.pdf","grobid_xml":"https://content.openalex.org/works/W1921787609.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W38490725","https://openalex.org/W950120787","https://openalex.org/W1847168837","https://openalex.org/W1986565745","https://openalex.org/W2008854521","https://openalex.org/W2014091144","https://openalex.org/W2015484447","https://openalex.org/W2033863809","https://openalex.org/W2042140648","https://openalex.org/W2062527635","https://openalex.org/W2064649894","https://openalex.org/W2148080316","https://openalex.org/W2152727843","https://openalex.org/W2156220037","https://openalex.org/W2167311298","https://openalex.org/W2301404923","https://openalex.org/W2418663713"],"related_works":["https://openalex.org/W2735148310","https://openalex.org/W1713204024","https://openalex.org/W2075873079","https://openalex.org/W2338146729","https://openalex.org/W2784892576","https://openalex.org/W2766902279","https://openalex.org/W1986565745","https://openalex.org/W2746139129","https://openalex.org/W2201687890"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Solanezumab":[1,108],"is":[2],"an":[3,146],"anti-amyloid":[4],"monoclonal":[5],"antibody":[6],"in":[7,63,93,152],"clinical":[8],"testing":[9],"for":[10],"treatment":[11,90,136],"of":[12,21,25,32,75,122,131,141],"Alzheimer's":[13,70],"disease":[14],"(AD).":[15],"Its":[16],"mechanism":[17],"suggests":[18],"the":[19,23,49,56,64,94,103,128,139,142,153],"possibility":[20],"slowing":[22],"progression":[24],"AD.":[26],"METHODS:":[27],"A":[28],"possible":[29],"disease-modifying":[30],"effect":[31],"solanezumab":[33,62],"was":[34,83,109],"assessed":[35],"using":[36],"a":[37,99],"new":[38,114],"statistical":[39],"method":[40],"including":[41],"noninferiority":[42],"testing.":[43],"Performance":[44],"differences":[45,54,82,91],"were":[46,117],"compared":[47],"during":[48],"placebo-controlled":[50,95,143],"period":[51,96],"with":[52],"performance":[53],"after":[55,102],"placebo":[57,104],"patients":[58,133],"crossed":[59],"over":[60],"to":[61],"delayed-start":[65,154],"period.":[66,155],"RESULTS:":[67],")":[68],"and":[69,112],"Disease":[71],"Cooperative":[72],"Study":[73],"Activities":[74],"Daily":[76],"Living":[77],"inventory":[78],"instrumental":[79],"items":[80],"(ADCS-iADL)":[81],"met":[84],"through":[85],"132":[86],"weeks,":[87],"indicating":[88],"that":[89,127],"observed":[92],"remained,":[97],"within":[98],"predefined":[100],"margin,":[101],"group":[105],"initiated":[106,135],"solanezumab.":[107],"well":[110],"tolerated,":[111],"no":[113],"safety":[115],"concerns":[116],"identified.":[118],"DISCUSSION:":[119],"The":[120],"results":[121],"this":[123],"secondary":[124],"analysis":[125],"show":[126],"mild":[129],"subgroup":[130],"solanezumab-treated":[132],"who":[134],"early,":[137],"at":[138,148],"start":[140],"period,":[144],"retained":[145],"advantage":[147],"most":[149],"time":[150],"points":[151]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1921787609","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":14},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":7}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
